Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.55 USD | +0.14% |
|
0.00% | +124.25% |
04/06 | Fusion Pharmaceuticals Says $2.4 Billion Acquisition by AstraZeneca Unit Is Complete | MT |
04/06 | Fusion Pharmaceuticals Inc.(NasdaqGS:FUSN) dropped from NASDAQ Biotechnology Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration- Stock Market
- Equities
- FUSN Stock
- News FUSN PHAR
- Jefferies Downgrades Fusion Pharmaceuticals to Hold From Buy, Raises Price Target to $21 From $10